about
Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophyEya4 Induces Hypertrophy via Regulation of p27kip1CD4+ Foxp3+ T-cells contribute to myocardial ischemia-reperfusion injury.Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.Cardiac catheter ablation under real-time magnetic resonance guidance.Impact of thoracic surgery on cardiac morphology and function in small animal models of heart disease: a cardiac MRI study in ratsFactor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarctionDouble Peripheral Venous and Arterial Cannulation for Extracorporeal Membrane Oxygenation in Combined Septic and Cardiogenic ShockMR safety: fast T₁ thermometry of the RF-induced heating of medical devices.Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles.Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonanceLocal versus global aortic pulse wave velocity in early atherosclerosis: An animal study in ApoE-/--mice using ultrahigh field MRICardiac amyloidosis mimicking severe aortic valve stenosis - a case report demonstrating diagnostic pitfalls and role of dobutamine stress echocardiography.Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y.5-Lipoxygenase facilitates healing after myocardial infarctionHigh-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease.Myocardial T1: quantification by using an ECG-triggered radial single-shot inversion-recovery MR imaging sequence.Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come?Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease.Role of Global Longitudinal Strain in the Prediction of Outcome in Patients With Severe Aortic Valve Stenosis.Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis.Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis.Long term evolution of magnetic resonance imaging characteristics in a case of atypical left lateral wall hypertrophic cardiomyopathy.Direct cooling of the catheter tip increases safety for CMR-guided electrophysiological proceduresConditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusion.Pacing lead inserted via the subclavian artery caused acute coronary syndrome.Effect of cardiac resynchronization therapy on the incidence of electrical storm.Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction.Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanics.Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease.Spatial distribution of RF-induced E-fields and implant heating in MRI.Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy.Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosages.Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy.Thrombus Aspiration for ST-Segment-Elevation Myocardial Infarction in Modern Era: Still an Issue of Debate?α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.Real-time magnetic resonance guidance of interventional electrophysiology procedures with passive catheter visualization and tracking.Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid Regurgitation.
P50
Q26750739-41C0DB8C-1406-4BA1-871C-12CE9C6AB4CFQ28582935-17C71A8F-861B-4F5E-ACE4-45E1EBCF57D4Q30313801-94EA3B35-48CB-4BAC-8024-928F2D95149FQ30315530-619B5802-018A-4395-8AA4-6072DBEDF53AQ30523824-7E29F667-C74D-43C7-BC5C-F5B69ECB4A65Q31130159-10B0ADF9-B8AA-4739-BE13-77F5FBC7D630Q33789267-64E2FC57-3A42-40C7-A4B6-12F7301F5715Q33878369-1725BE41-7651-4154-993F-B7A122578A49Q34144344-731BCE68-8EA6-4400-BF51-5C998908B2BEQ36081133-8EE64CD7-3618-4353-8B62-911FB4EC550FQ36130156-3D72E8D1-7A2F-4036-97F1-61A9BE898465Q36282540-F3E96040-94E5-4719-A08A-288005674B22Q36318806-940AD394-B95B-419D-94FF-F0D02956E508Q36819212-073E50B9-94E3-4FDC-A041-39317E8B496CQ37004832-3CABB84B-8BBD-400E-8198-4B5862807973Q37076050-ACAD0D8D-9E09-489C-AB8E-A3381446F525Q38267903-545CAD11-9E37-442C-9DD8-2D56FA45643EQ38386243-EBD689B4-A439-4FF5-80A4-E7397ED6A5F6Q38662053-118EA385-FF68-43D3-950A-8E867E96F3F9Q38710050-FD6C1551-9A36-4F69-8670-5B911BE1DEF2Q39707639-87D61543-6180-4A5A-AC8B-80FDA9DD458AQ41582133-A48CED5D-437A-4E1E-90BF-5B77D80E098BQ41924604-B3DBA4D2-1D8B-415B-AB9E-D72806F7E108Q41992195-408CBA76-A6A8-4AD3-8EFE-B1574C284172Q42608974-BD355582-9BBE-4111-AEFF-8CBB1C291782Q42870186-1BCE1B82-3174-4DB5-94E4-EE0234FEA943Q44950560-EC10B081-C155-4449-8BE4-2AE224279A92Q45007072-5874E108-E85B-44B9-8A38-260720909C02Q45216531-C2D36B24-2592-4497-B14A-E3F7BEBD8683Q46895540-2529F4EE-0E37-4859-96CA-1ACDEF03BFC0Q47134914-F5802F98-5B6F-4B46-B4F6-A2FA1CF12CCDQ47425101-8173C015-2E08-4790-8980-1CC3794B2614Q48118068-CF2BAE80-63F1-4C73-8C27-6A88CAB76030Q49548756-D2CBDC0A-8F69-4A9D-9306-55A6377DAA42Q49922593-F9030508-5762-4C36-82B6-E61547C8B48EQ50085399-68C57980-54E0-4888-B4B1-70A6ABC087ADQ50091253-10278ED5-2D73-4C10-8485-57E3D41E2E42Q50224036-9145E494-979F-427C-8071-16142726C982Q50667399-01D855A3-9812-457D-B8D8-9AA8392D20E6Q51041731-C042D4B3-2CDB-41B9-A2D9-1005418F38F4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Peter Nordbeck
@ast
Peter Nordbeck
@en
Peter Nordbeck
@es
Peter Nordbeck
@fr
Peter Nordbeck
@nl
Peter Nordbeck
@sl
type
label
Peter Nordbeck
@ast
Peter Nordbeck
@en
Peter Nordbeck
@es
Peter Nordbeck
@fr
Peter Nordbeck
@nl
Peter Nordbeck
@sl
prefLabel
Peter Nordbeck
@ast
Peter Nordbeck
@en
Peter Nordbeck
@es
Peter Nordbeck
@fr
Peter Nordbeck
@nl
Peter Nordbeck
@sl
P214
P1053
D-4771-2018
P106
P21
P214
P31
P3829
P496
0000-0002-2560-4068
P735
P7859
viaf-50369472